Skip to main content

Animations

MJFF Publications

8581 - 8590 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2021
  • 2025
  • 2021
  • 2024
  • 2018
  • 2021
  • 2023
  • 2017
  • 2021
  • Summary Details
    OPEN
    Title: Key Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein Spreading
    Journal Name: Advanced Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/advs.202413052
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson’s disease
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00088-6
    Citation Count: 62
  • Summary Details
    OPEN
    Title: Spatial genomics of AAV vectors reveals mechanism of transcriptional crosstalk that enables targeted delivery of large genetic cargo
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41587-025-02565-4
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01233-3
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Peripheral immune cell abundance differences link blood mitochondrial DNA copy number and Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00831-x
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.004
    Citation Count: 125
  • Summary Details
    OPEN
    Title: Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivo
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.2108489118
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Serotonergic and dopaminergic control of impulsivity in gambling disorder
    Journal Name: Addiction Biology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/adb.13264
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
    Journal Name: British Journal of Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/bph.14123
    Citation Count: 20
  • Summary Details
    OPEN
    Title: echolocatoR : an automated end-to-end statistical and functional genomic fine-mapping pipeline
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btab658
    Citation Count: 27
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.